Reference number : 276-2010-2011-Q2-00287, amendment number : , agreement type : C, recipient legal name : Soricimed Biopharma Inc.|Soricimed Biopharma Inc., recipient country : CA, recipient province : NB, recipient city : Moncton|Moncton, recipient postal code : E1C 4W7, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 195243, agreement title french : 195243, agreement number : 195243, agreement value : 2896394.0, agreement start date : 2010-09-10, agreement end date : 2012-08-31, description english : Soricidin-Derived Peptides for Targeted Cancer Management, description french : Peptide dérivé de la soricidine pour traitement du cancer, expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution. The total government funding is $3,393,394.00., additional information french : Le type d'aide est Contribution à remboursement conditionnel. Le financement gouvernemental total est 3 393 394,00 $., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique